Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merle Freitag

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Arthritis Research & Therapy|December 13, 2024
Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case studyMaren Claus, Merle Freitag, Meike Ewald, et al.
Rheumatology (Oxford, England)|December 3, 2025
Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T-cell therapyMerle Freitag, Philipp Kolb, Valeria Falcone, et al.
Science Translational Medicine|May 13, 2026
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblastsWolfgang Merkt, Lea Rodon, Franca S Deicher, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Arthritis Research & Therapy|December 13, 2024
Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case studyMaren Claus, Merle Freitag, Meike Ewald, et al.
Rheumatology (Oxford, England)|December 3, 2025
Fcγ-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T-cell therapyMerle Freitag, Philipp Kolb, Valeria Falcone, et al.
Science Translational Medicine|May 13, 2026
Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblastsWolfgang Merkt, Lea Rodon, Franca S Deicher, et al.
Pageof 1